NPS PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)
NPS PHARMACEUTICALS INC reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) of 560.00% for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm · last filed 2013-05-09
- NPS PHARMACEUTICALS INC share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term (deprecated 2012-01-31) for the quarter ending 2013-03-31 was 560.00%.
- NPS PHARMACEUTICALS INC share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term (deprecated 2012-01-31) for fiscal 2012 was 571.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) 12 month |
|---|---|---|
| 2013-03-31 | 560.00% 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 571.00% 10-K · filed 2013-02-21 |